Guidance for industry : Q3B(R2) impurities in new drug products.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), International Conference on Harmonisation
Format:	Government Document Conference Proceeding eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
Subjects:	Drug development > Government policy > United States. Drug adulteration > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113762

Description
Item Description:	Title from PDF title page (viewed on June 15, 2009). "ICH". "July 2006". "Revision 2". Electronic resource.
Physical Description:	8 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA web site. Address as of 6/15/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128033.pdf ; current access is available via PURL.